pilocarpine has been researched along with Cancer of Salivary Gland in 2 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Licht, R | 1 |
| Kampinga, HH | 1 |
| Coppes, RP | 1 |
| Ancri, D | 1 |
| Laudenbach, P | 1 |
| Szabo, G | 1 |
2 other studies available for pilocarpine and Cancer of Salivary Gland
| Article | Year |
|---|---|
Salivary gland-sparing prophylactic pilocarpine treatment has no effect on tumor regrowth after irradiation.
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Dose-Response Relationship, Radiation; Humans; Mic | 2002 |
[A new radionucleid test on salivary gland function].
Topics: Atropine; Humans; Parotid Gland; Pilocarpine; Radionuclide Imaging; Salivary Gland Diseases; Salivar | 1973 |